Clinicopathological Analysis of Acquired Melanocytic Nevi and a Preliminary Study on the Possible Origin of Nevus Cells.
Journal
The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
28
12
2019
medline:
27
3
2021
entrez:
28
12
2019
Statut:
ppublish
Résumé
The pathogenesis of acquired melanocytic nevi (AMN) is still unclear, and the origin of nevus cells has not been clarified. To analyze the clinical features and pathological types of AMN and identify the possible origin of nevus cells. A retrospective study of 2929 cases of AMN was conducted, and 96 specimens of intradermal and junctional nevi were selected. Immunohistochemical assays were performed to detect the expression of basement membrane component receptor DDR-1 and the molecular markers on epidermal melanocytes, dermal stem cells (DSCs), and hair follicle stem cells. Junctional nevi and compound nevi were prone to occur on glabrous skin, such as the palms, soles, and vulva, and on the extremities in children, whereas intradermal nevi tended to develop on the trunk, head, and face of adults. The immunohistochemical data revealed that both junctional nevi and intradermal nevi expressed the epidermal melanocyte surface markers E-cadherin, DDR-1, and integrin α6 and the DSC molecular markers NGFRp-75 and nestin. CD34 was expressed only in junctional nevi, whereas K19 was not expressed in any type of melanocytic nevi. There was no significant difference in molecular expression at different sites or in different ages of onset. Nestin expression was markedly stronger in the intradermal nevi than in the junctional nevi, but there was no difference between the superficial and deep nevus cell nests of intradermal nevi. AMN may have a multicellular origin that commonly follows the mode of Abtropfung. Furthermore, DSCs may partly or independently participate in the formation of nevus cells.
Sections du résumé
BACKGROUND
BACKGROUND
The pathogenesis of acquired melanocytic nevi (AMN) is still unclear, and the origin of nevus cells has not been clarified.
OBJECTIVE
OBJECTIVE
To analyze the clinical features and pathological types of AMN and identify the possible origin of nevus cells.
METHODS
METHODS
A retrospective study of 2929 cases of AMN was conducted, and 96 specimens of intradermal and junctional nevi were selected. Immunohistochemical assays were performed to detect the expression of basement membrane component receptor DDR-1 and the molecular markers on epidermal melanocytes, dermal stem cells (DSCs), and hair follicle stem cells.
RESULTS
RESULTS
Junctional nevi and compound nevi were prone to occur on glabrous skin, such as the palms, soles, and vulva, and on the extremities in children, whereas intradermal nevi tended to develop on the trunk, head, and face of adults. The immunohistochemical data revealed that both junctional nevi and intradermal nevi expressed the epidermal melanocyte surface markers E-cadherin, DDR-1, and integrin α6 and the DSC molecular markers NGFRp-75 and nestin. CD34 was expressed only in junctional nevi, whereas K19 was not expressed in any type of melanocytic nevi. There was no significant difference in molecular expression at different sites or in different ages of onset. Nestin expression was markedly stronger in the intradermal nevi than in the junctional nevi, but there was no difference between the superficial and deep nevus cell nests of intradermal nevi.
CONCLUSION
CONCLUSIONS
AMN may have a multicellular origin that commonly follows the mode of Abtropfung. Furthermore, DSCs may partly or independently participate in the formation of nevus cells.
Identifiants
pubmed: 31880593
doi: 10.1097/DAD.0000000000001599
pii: 00000372-202006000-00005
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
414-422Références
Magana-Garcia M, Ackerman AB. What are nevus cells? Am J Dermatopathol. 1990;12:93–102.
Pg U. Naevi und naevocarcinome. Berl Klin Wochenschr. 1893;30:14–16.
Worret WI, Burgdorf WH. Which direction do nevus cells move? Abtropfung reexamined. Am J Dermatopathol. 1998;20:135–139.
Krengel S. Nevogenesis—new thoughts regarding a classical problem. Am J Dermatopathol. 2005;27:456–465.
Grichnik JM, Ross AL, Schneider SL, et al. How, and from which cell sources, do nevi really develop? Exp Dermatol. 2014;23:310–313.
Zabierowski SE, Fukunaga-Kalabis M, Li L, et al. Dermis-derived stem cells: a source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res. 2011;24:422–429.
Li L, Fukunaga-Kalabis M, Herlyn M. Isolation and cultivation of dermal stem cells that differentiate into functional epidermal melanocytes. Methods Mol Biol. 2012;806:15–29.
Masson P. My conception of cellular nevi. Cancer. 1951;4:9–38.
Cramer SF. The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol. 1984;6:289–298.
Cramer SF. Nevus cells of nerve sheath origin? Arch Dermatol. 1990;126:1367–1368.
Van Raamsdonk CD, Deo M. Links between schwann cells and melanocytes in development and disease. Pigment Cell Melanoma Res. 2013;26:634–645.
Zattra E, Fortina AB, Bordignon M, et al. Immunosuppression and melanocyte proliferation. Melanoma Res. 2009;19:63–68.
Zhao Z, Jin C, Ding K, et al. Dedifferentiation of human epidermal melanocytes into melanoblasts in vitro. Exp Dermatol. 2012;21:504–508.